Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide- induced acute lung injury

Journal of Surgical Research

Volumn 165, Issue 1, 2011, Pages 142-150

  Hidaka, Seigo ^a   Iwasaka, Hideo ^a   Hagiwara, Satoshi ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Acute lung injury; Gabexate mesilate; HMGB1; Lipopolysaccharide

Indexed keywords

CYTOKINE; GABEXATE MESILATE; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE ACTIVATED RECEPTOR 2;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HISTOPATHOLOGY; IN VITRO STUDY; LUNG EDEMA; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; SUPERNATANT; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ANIMALS; DNA; GABEXATE; HMGB1 PROTEIN; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MALE; NF-KAPPA B; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, WISTAR; SERINE PROTEINASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78649980480     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.05.039     Document Type: Article

References (33)

1. G.S. Martin, D.M. Mannino, and S. Eaton The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546
2. D.L. Wyncoll, and T.W. Evans Acute respiratory distress syndrome Lancet 354 1999 497
3. N.C. Riedemann, R.F. Guo, and P.A. Ward The enigma of sepsis J Clin Invest 15 112 2003 460
4. H. Wang, H. Yang, and C.J. Czura HMGB1 as a late mediator of lethal systemic inflammation Am J Respir Crit Care Med 164 2001 1768
5. M. Bustin Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins Mol Cell Biol 19 1999 5237
6. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248
7. C. Fiuza, M. Bustin, and S. Talwar Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2003 2652
8. H. Wang, J.M. Vishnubhakat, and O. Bloom Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes Surgery 126 1999 389
9. D. Yang, Q. Chen, and H. Yang High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin J Leukoc Biol 81 2007 59
10. J. Li, R. Kokkola, and S. Tabibzadeh Structural basis for the proinflammatory cytokine activity of high mobility group box 1 Mol Med 9 2003 37
11. E. Abraham, J. Arcaroli, and A. Carmody HMGB1 as a mediator of acute lung inflammation J Immunol 165 2000 2950
12. K. Murakami, K. Okajima, and M. Uchiba Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes Crit Care Med 24 1996 1047
13. S. Aosasa, S. Ono, and H. Mochizuki Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor α production of monocytes Shock 15 2001 101
14. M. Uchiba, K. Okajima, and C. Kaun Gabaxate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro Crit Care Med 31 2003 1147
15. K. Murakami, R. McGuire, and R.A. Cox Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep Shock 18 2002 236
16. H. Ueno, T. Matsuda, and S. Hashimoto Contributions of high mobility group box protein in experimental and clinical acute lung injury Am J Respir Crit Care Med 170 2004 1310
17. H. Wang, H. Yang, and K.J. Tracey Extracellular role of HMGB1 in inflammation and sepsis J Intern Med 255 2004 320
18. S. Idell Coagulation, fibrinolysis, and fibrin deposition in acute lung injury Crit Care Med 31 4 Suppl 2003 S213
19. R.M. Mesters, N. Florke, and H. Ostermann Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis Thromb Haemost 75 1996 902
20. J.E. Kaplan, and A.B. Malik Thrombin-induced intravascular coagulation: Role in vascular injury Semin Thoromb Hemost 13 1987 398
21. N. Hasegawa, A.W. Husari, and W.T. Hart Role of the coagulation system in ARDS Chest 105 1994 268
22. A.J.G. Horrevoets Plasminogen activator inhibitor 1 (PAI-1): In vitro activities and clinical relevance Br J Haematol 125 2004 12
23. C. Fiuza, M. Bustin, and S. Talwar Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2003 2652
24. M. Chignard, and D. Pidard Neutrophil and pathogen proteinases versus proteinase-activated receptor-2 lung epithelial cells: More terminators than activators Am J Respir Cell Mol Biol 34 2006 394
25. G. Grandaliano, P. Pontrelli, and G. Cerullo Protease-activated receptor-2 expression in IgA nephropathy: A potential role in the pathogenesis of interstitial fibrosis J Am Soc Nephrol 14 2003 2072
26. M. Bhatia, and S. Moochhala Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome J Pathol 202 2004 145
27. P.C. Heinrich, I. Behrmann, and S. Haan Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 15;374 Pt 1 2003 1
28. D.G. Remick, G.R. Bolgos, and J. Siddiqui Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days Shock 17 2002 463
29. I.M. Adcock Transcription factors as activators of gene transcription: AP-1 and NF-κB Monaldi Arch Chest Dis 52 1997 178
30. I.E. Dumitriu, P. Baruah, and B. Valentinis Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products J Immunol 174 2005 7506
31. H.J. Kwak, J.S. Song, and J.Y. Heo Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-κB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation J Pharmacol Exp Ther 315 2005 1188
32. A.J. Schottelius, M.W. Mayo, and R.B. Sartor Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding J Biol Chem 274 1999 31868
33. M. Yuksel, K. Okajima, and M. Uchiba Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kB and activator protein-1 in human monocytes J Pharmacol Exp Ther 305 2003 298